The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Pfizer
Evaluation of cytokine release syndrome (CRS) in patients with relapsed or refractory multiple myeloma (RRMM) receiving step-up priming doses and longer dosing intervals of elranatamab: MagnetisMM-9.
 
Douglas W. Sborov
Consulting or Advisory Role - Abbvie; Arcellx; AstraZeneca; BiolineRx; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Research Funding - Pfizer
 
Charlotte Pawlyn
Honoraria - Abbvie; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Sanofi
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; ITeos Therapeutics (Inst); Janssen; Pfizer (Inst); Sanofi
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Janssen (Inst)
 
Tadao Ishida
Honoraria - Bristol Myers Squibb; Janssen; Ono Yakuhin; Sanofi; Takeda
Research Funding - Alexionpharma (Inst); Bristol Myers Squibb (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Pfizer (Inst); Prothena (Inst); Sanofi (Inst); Takeda (Inst)
 
Jeffrey S.Y. Huang
Honoraria - Celgene; Janssen; Takeda
Consulting or Advisory Role - Celgene; Janssen; Takeda
 
Reuben Benjamin
Other Relationship - Celgene
 
Shinsuke Iida
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Janssen; Sanofi; Takeda
Research Funding - Abbvie; Amgen; Bristol-Myers Squibb; Caelum Biosciences; Celgene; Daiichi Sankyo; Janssen; Ono Pharmaceutical; Otsuka; Sanofi; Takeda
 
Rakesh Popat
Honoraria - Bristol-Myers Squibb/Celgene
Consulting or Advisory Role - Celgene; Galapagos NV; GlaxoSmithKline; Janssen; Roche
Speakers' Bureau - Abbvie; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Johnson & Johnson/Janssen; Pfizer
Research Funding - GlaxoSmithKline (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen
 
Junya Kuroda
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Janssen; Kyowa Kirin; Ono Pharmaceutical; Sanofi
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Janssen
Research Funding - Bristol-Myers Squibb; Chugai Pharma; Kyowa Kirin; Ono Pharmaceutical; Shionogi
 
Matthew James Pianko
Consulting or Advisory Role - GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Pfizer; Sanofi; Trillium Therapeutics
Research Funding - Abbvie (Inst); Ascentage Pharma (Inst); Bristol-Myers Squibb/Celgene (Inst); Ipsen (Inst); Janssen (Inst); Nektar (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
 
Aravind Ramakrishnan
No Relationships to Disclose
 
Steven Robert Schuster
No Relationships to Disclose
 
Vrushali S. Dabak
No Relationships to Disclose
 
Alexander M. Lesokhin
Honoraria - ITeos Therapeutics; Janssen; Legend Biotech; Pfizer; Sanofi; SVB Leerink; SVB Leerink; Trillium Therapeutics
Consulting or Advisory Role - Arcellx; Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
 
Umberto Conte
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Pooneh Soltantabar
Employment - Pfizer
 
Fangxin Hong
No Relationships to Disclose
 
Erik Vandendries
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Rafael Fonseca
Employment - Mayo Clinic; Mayo Clinic
Leadership - Antengene
Stock and Other Ownership Interests - Adaptive Biotechnologies; Caris Life Sciences; OncoMyx Therapeutics
Honoraria - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; OncoTracker; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; Oncopeptides; OncoTracker; Pfizer; Pharmacyclics; RA Capital; Regeneron; Sanofi; Takeda
Patents, Royalties, Other Intellectual Property - Dr Fonseca has received a patent for the prognostication of MM based on genetic categorization of the disease.
Travel, Accommodations, Expenses - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; OncoTracker; Sanofi; Takeda
Other Relationship - Adaptive Biotechnologies; Caris Life Sciences